Biosimilars and the future of more affordable treatment for hematologic malignancies
Upcoming trials for DLBCL: R-CHOP with acalabrutinib and obinutuzumab with checkpoint inhibitor
What should the future of cancer treatment and research look like?
The origin and work of the International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
Is venetoclax appropriate for relapsed CLL patients?